Ascendis Pharma A/S (ASND)

Ascendis Pharma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	625.52	392.16	444.77	446.27	584.52	598.11
Short-Term Investments	-	7.28	290.69	235.8	134.28	-
Cash & Short-Term Investments	625.52	399.44	735.46	682.06	718.8	598.11
Cash Growth	37.35%	-45.69%	7.83%	-5.11%	20.18%	115.25%
Accounts Receivable	33.1	35.87	11.91	2.2	0.39	0.8
Other Receivables	17.25	19.9	13.72	20.99	6.96	4.61
Receivables	50.35	55.77	25.63	23.19	7.34	5.41
Inventory	265.43	208.93	130.67	75.41	-	-
Prepaid Expenses	32.44	38.58	31.72	25.23	13.99	7.65
Total Current Assets	973.74	702.72	923.47	805.89	740.13	611.17
Property, Plant & Equipment	97.52	110.63	129.1	126.05	108.11	45.07
Long-Term Investments	16.21	5.69	30.42	145.91	124.46	15.54
Goodwill	-	3.5	3.5	3.5	3.5	3.5
Other Intangible Assets	4.11	0.92	1.33	1.78	2.22	-
Other Long-Term Assets	2.2	2.13	1.92	1.81	1.38	1.46
Total Assets	1,094	825.59	1,090	1,085	979.79	676.73
Accounts Payable	75.27	94.57	101.03	59.42	21.9	27.77
Accrued Expenses	42.24	41.18	31.99	29.95	23.38	13.35
Current Portion of Long-Term Debt	435.32	11.23	11.63	-	-	-
Current Portion of Leases	14.42	14.17	13.79	7	6.86	5.9
Current Income Taxes Payable	1.02	2.3	5.49	0.2	0.3	0.12
Current Unearned Revenue	1.59	1.18	-	2.6	0.36	0.86
Other Current Liabilities	268.61	32.72	7.34	1.19	-	-
Total Current Liabilities	838.46	197.34	171.27	100.36	52.8	47.99
Long-Term Debt	263.55	534.25	387.56	-	-	-
Long-Term Leases	75.38	84.62	95.4	97.97	85.12	30.72
Long-Term Unearned Revenue	5	5.95	14.21	2.96	-	-
Long-Term Deferred Tax Liabilities	8.72	5.83	-	-	-	-
Other Long-Term Liabilities	-	143.3	157.95	-	3.16	0.91
Total Liabilities	1,191	971.28	826.39	201.29	141.08	79.62
Common Stock	8.14	7.75	7.68	7.65	7.22	6.44
Additional Paid-In Capital	2,441	2,123	2,113	2,108	1,729	1,122
Retained Earnings	-2,547	-2,277	-1,860	-1,236	-1,030	-611.32
Treasury Stock	-0.12	-0.15	-0.15	-0.02	-	-
Comprehensive Income & Other	0.95	0.72	3.45	3.78	133.03	79.9
Shareholders' Equity	-97.32	-145.7	263.35	883.64	838.71	597.11
Total Liabilities & Equity	1,094	825.59	1,090	1,085	979.79	676.73
Total Debt	788.66	644.27	508.38	104.96	91.98	36.62
Net Cash (Debt)	-163.15	-244.83	234.57	684.66	742.1	561.49
Net Cash Growth	-	-	-65.74%	-7.74%	32.17%	102.07%
Net Cash Per Share	-2.86	-4.35	4.18	12.50	14.66	12.07
Filing Date Shares Outstanding	59.76	56.61	56.04	56.78	53.75	47.99
Total Common Shares Outstanding	59.76	56.61	56.04	56.78	53.75	47.99
Working Capital	135.28	505.38	752.2	705.53	687.33	563.18
Book Value Per Share	-1.63	-2.57	4.70	15.56	15.60	12.44
Tangible Book Value	-101.43	-150.12	258.52	878.36	832.99	593.62
Tangible Book Value Per Share	-1.70	-2.65	4.61	15.47	15.50	12.37
Machinery	-	38.86	36.15	25.77	19.8	11.98
Leasehold Improvements	-	19.38	20.13	18.07	8.54	4.29

Source: S&P Capital IQ. Standard template. Financial Sources.